Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

295 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Active, Not Recruiting

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT04704921

Conditions
AMD, CNV, Choroid Diseases, +18 more
Locations
  • Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
  • Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

NCT06088979

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - Site 840-121 Tucson, Arizona, United States
  • Foothill Eye Institute - Site 840-116 Pasadena, California, United States
  • University of California Davis Eye Center - Site 840-119 Sacramento, California, United States
  • The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122 San Francisco, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Rate of Progression in EYS Related Retinal Degeneration

NCT04127006

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Retina Associates Denver, Colorado, United States
  • Vitreo-Retinal Associates Gainesville, Florida, United States
  • University of Miami: Neuro-ophthalmology Department Miami, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

NCT03326336

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +7 more
Locations
  • UPMC Eye Center Pittsburgh, Pennsylvania, United States
  • Centre Hospitalier National d'Ophtalmologie (CHNP) des Quinze-Vingts Paris, France
  • Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London, United Kingdom
View Trial Details
Active, Not Recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, Not Recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Retina Consultants of Texas Bellaire, Texas, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

NCT05536973

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
Locations
  • Adverum Clinical Site 178 Phoenix, Arizona, United States
  • Adverum Clinical Site 126 Phoenix, Arizona, United States
  • Adverum Clinical Site 159 Tucson, Arizona, United States
  • Adverum Clinical Site 100 Beverly Hills, California, United States
View all 39 locations
View Trial Details

Related conditions